The p38α mitogen-activated protein kinase as a central nervous system drug discovery target
<p>Abstract</p> <p>Protein kinases are critical modulators of a variety of cellular signal transduction pathways, and abnormal phosphorylation events can be a cause or contributor to disease progression in a variety of disorders. This has led to the emergence of protein kinases as...
Main Authors: | Van Eldik Linda J, de Almeida Lucia, Borders Aaron S, Watterson D Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | BMC Neuroscience |
Similar Items
-
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
by: Utid Suriya, et al.
Published: (2022-07-01) -
p38 mitogen‐activated protein kinase: Functions and targeted therapy in diseases
by: Qinwen Zheng, et al.
Published: (2023-09-01) -
Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1.
by: De Nicola, G, et al.
Published: (2013) -
Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1
by: De Nicola, G, et al.
Published: (2013) -
Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38.
by: Clark, A, et al.
Published: (2003)